Spatial modeling of visual field data for assessing glaucoma progression

B.D. Betz-Stablein, William Morgan, Philip House, M.L. Hazelton

Research output: Contribution to journalArticlepeer-review

15 Citations (Scopus)


Purpose. In order to reduce noise and account for spatial correlation, we applied disease mapping techniques to visual field (VF) data. We compared our calculated rates of progression to other established techniques. Methods. Conditional autoregressive (CAR) priors, weighted to account for physiologic correlations, were employed to describe spatial and spatiotemporal correlation over the VF. Our model is extended to account for several physiologic features, such as the nerve fibers serving adjacent loci on the VF not mapping to the adjacent optic disc regions, the presence of the blind spot, and large measurement fluctuation. The models were applied to VFs from 194 eyes and fitted within a Bayesian framework using Metropolis-Hastings algorithms. Results. Our method (SPROG for Spatial PROGgression) showed progression in 42% of eyes. Using a clinical reference, our method had the best receiver operating characteristics compared with the point-wise linear regression methods. Because our model intrinsically accounts for the large variation of VF data, by adjusting for spatial correlation, the effects of outliers are minimized, and spurious trends are avoided. Conclusions. By using CAR priors, we have modeled the spatial correlation in the eye. Combining this with physiologic information, we are able to provide a novel method for VF analysis. Model diagnostics, sensitivity, and specificity show our model to be apparently superior to current point-wise linear regression methods. ( number, ACTRN12608000274370). © 2013 The Association for Research in Vision and Ophthalmology, Inc.
Original languageEnglish
Pages (from-to)1544-1553
JournalInvestigative Ophthalmology and Visual Science
Issue number2
Publication statusPublished - 2013


Dive into the research topics of 'Spatial modeling of visual field data for assessing glaucoma progression'. Together they form a unique fingerprint.

Cite this